INSOMNIA is the #8 most commonly reported adverse reaction for LISDEXAMFETAMINE DIMESYLATE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 1,430 FDA adverse event reports linking LISDEXAMFETAMINE DIMESYLATE to INSOMNIA. This represents approximately 2.2% of all 65,887 adverse event reports for this drug.
Patients taking LISDEXAMFETAMINE DIMESYLATE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA1,430 of 65,887 reports
INSOMNIA is a less commonly reported adverse event for LISDEXAMFETAMINE DIMESYLATE, but still significant enough to appear in the safety profile.
Other Side Effects of LISDEXAMFETAMINE DIMESYLATE
In addition to insomnia, the following adverse reactions have been reported for LISDEXAMFETAMINE DIMESYLATE:
INSOMNIA has been reported as an adverse event in 1,430 FDA reports for LISDEXAMFETAMINE DIMESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with LISDEXAMFETAMINE DIMESYLATE?
INSOMNIA accounts for approximately 2.2% of all adverse event reports for LISDEXAMFETAMINE DIMESYLATE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking LISDEXAMFETAMINE DIMESYLATE?
If you experience insomnia while taking LISDEXAMFETAMINE DIMESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.